What is the issue size of Jupiter Life Line IPO?

The issue size of the Jupiter Life Line IPO is Rs 869.08 crores

What is 'pre-apply' for Jupiter Life Line IPO?

Pre-apply will alow you to apply for the Jupiter Life Line IPO 2 days before the subscription period starts.

If I pre-apply for Jupiter Life Line IPO, when will my order get placed?

Your order will be placed on the exchange as soon as the Jupiter Life Line IPO bidding starts. You will receive a UPI request within 24 hours after the bidding period opens.

When will I know if my Jupiter Life Line IPO order is placed?

We will notify you when your Jupiter Life Line IPO order is placed with the exchange.

What are the open and close dates of the for Jupiter Life Line IPO?

Jupiter Life Line IPO will be open between 6 Sept - 8 Sept, 2023.

What is the lot size and minimum order quantity of the Jupiter Life Line IPO?

Jupiter Life Line Limited IPO lot size is 20 shares.

What are the allotment dates for the Jupiter Life Line IPO?

Jupiter Life Line IPO allotment date is 13 Sept, 2023. For Jupiter Life Line IPO allotment status check, you can visit the website of the registrar of the IPO.

Who is the registrar of Jupiter Life Line IPO?

Jupiter Life Line IPO registrar is Kfin Technologies Limited. You can check Jupiter Life Line IPO allotment status on the website of the registrar.

Where is the Jupiter Life Line IPO getting listed?

The shares are proposed to be listed on BSE and NSE.

Jupiter Life Line IPO

Jupiter Life Line Limited

₹13,900 /20 sharesMinimum Investment

Jupiter Life Line IPO Listing DetailsListed OnIssue PriceListing PriceListing Gains
BSE & NSE₹735.00₹973.00₹238.00 (32.38%)
Jupiter Life Line IPO DetailsBidding DatesMin. InvestmentLot SizePrice Range
6 Sep ‘23 - 8 Sep ‘23₹13,90020₹695 - ₹735
Issue SizeIPO Doc
869.08CrRHP PDF
Subscription Status As on 08 Sep '23, 5:00 PMQualified Institutional Buyers
187.32x
Non-Institutional Investor
34.75x
Retail Individual Investor
7.73x
Employees
0.00x
Total
63.72x
About Jupiter Life LineJupiter Life Line was incorporated in 2002. It is a healthcare institution in the Mumbai Metropolitan Area (MMR) and western India. With a combined bed capacity of 1,194 as of March 31, 2023, spread across three hospitals, they have been serving the community for over 15 years as a quaternary healthcare provider in densely populated areas in the western region of India. Jupiter operates hospitals in Thane, Pune, and Indore, all under the Jupiter brand.
Their medical services encompass various specialties, including organ transplants, oncology, orthopedics, cardiology, pediatrics, neurology, and neurosurgery. Additionally, they offer specialized quaternary services and precision-based treatments like brachytherapy, radiotherapy, robotic knee replacement, and robotic neurorehabilitation.;
Parent Organisation
Jupiter Life Line Limited
Founded
2002
Managing Director
Dr. Ajay Thakker
Strengths & Risks
Jupiter Life Line has a combined bed capacity of 1,194 hospital beds across three hospitals in Thane, Pune, and Indore as of March 31, 2023.
Their hospitals have over 30 specialized medical fields, including organ transplant, oncology, orthopedics, cardiology, pediatrics, neurology, neurosurgery, and specialized quaternary services. Cutting-edge treatments like brachytherapy, radiotherapy, robotic knee replacement, and robotic neurorehabilitation are also offered.
The Thane and Indore hospitals offer neuro-rehabilitation services through a dedicated robotic and computer-assisted neuro-rehabilitation center. 
The Thane hospital was also honored with the Midday's Iconic Center for Neurology and Rehabilitation Award at International Health & Wellness Icons. It is also home to one of the few multi-organ transplant centers in Thane.
The hospital served 447,573 patients in 2021, 645,446 in 2022, and 773,937 in 2023, combining inpatient and outpatient care. Their healthcare team comprises 1,306 doctors, 1,416 nurses, and 1,585 other professionals as of March 31, 2023.
Across their three hospitals, they provide an operational bed capacity of 950 beds as of March 31, 2023. 
Each of these hospitals has achieved certification from NABH and accreditation in medical testing by NABL. Furthermore, the Thane hospital has also earned the NABH Safe-I certification and the NABH 'Nursing Excellence' accreditation.
Their revenue from operations displayed growth, increasing by 50.80% from Rs. 486.16 crore in 2021 to Rs. 733.12 crore in 2022 and further by 21.75% to Rs. 892.54 crore in 2023.
The company heavily relies on its Thane hospital for revenue. Any issues affecting the hospital in Thane or changes in the economic or political environment in western India, especially around Thane, could significantly harm the company's financial condition.
There are ongoing legal disputes against the company, its promoters, directors, and subsidiaries.
In 2021, the company recorded a loss of Rs. 2.30 crore, mainly due to the COVID-19 pandemic. Additionally, its subsidiaries have experienced losses and negative cash flows.
The company faces risks related to handling personal information, including medical data.
The company's bed occupancy rates are lower than most hospitals, which may require offering services at discounted rates to attract patients.
Maintaining the right doctor-patient ratio is essential for the company's operations. A shortfall in this ratio could adversely affect business and financial conditions.
As of March 31, 2023, the company had substantial borrowings of Rs. 476.37 crore.
Financials
*All values are in Rs. Cr
No Graph Data To Display
Application detailsApply asPrice bandApply upto
Regular₹695 - 735₹2 Lakh
High Networth Individual₹695 - 735₹2 - 5 Lakh
For Jupiter Life Line IPO, eligible investors can apply as Regular.

Listed On	Issue Price	Listing Price	Listing Gains
BSE & NSE	₹735.00	₹973.00	₹238.00 (32.38%)

Bidding Dates	Min. Investment	Lot Size	Price Range
6 Sep ‘23 - 8 Sep ‘23	₹13,900	20	₹695 - ₹735

Issue Size	IPO Doc
869.08Cr	RHP PDF

Apply as	Price band	Apply upto
Regular	₹695 - 735	₹2 Lakh
High Networth Individual	₹695 - 735	₹2 - 5 Lakh

Vaishnavi Tech Park, 3rd & 4th Floor
Sarjapur Main Road, Bellandur
Bengaluru – 560103
Contact Us
PRODUCTS
StocksFutures & OptionsIPOMutual FundsCreditBill Payments
GROWW
About UsPricingBlogMedia & PressCareersHelp and Support
QUICK LINKS
AMC Mutual FundsCalculatorsGlossaryOpen Demat AccountGroww DigestSitemap
ⓒ 2016-2023 Groww. All rights reserved, Built with ♥in India

ABOUT GROWW

Groww is India’s growing financial services platform where users can find their investment solutions pertaining to mutual funds, stocks, US Stocks, ETFs, IPO, and F&Os, to invest their money without hassles.

Groww objectively evaluates stocks and mutual funds and does not advise or recommend any stocks, mutual funds or portfolios. Investors shall invest at their own discretion, will and consent. Groww, at any time, does not guarantee fixed returns on the capital invested.

Groww helps investors -

· By providing 100% paperless online free Demat and trading account opening

· By providing an objective evaluation of products available on the platform

· By being transparent about fees and charges involved while investing in a product

· By offering decision-making assistance by providing technical analysis with advanced charts, well-designed line & candlestick charts that indicate share price movements, and market indices, along with more details about all registered and listed companies

SECURE TRANSACTIONS ON GROWW

All transactions on Groww are safe and secure. Users can invest through SIP or Lumpsum using Netbanking through all supported banks. It uses BSE Star MF (with Member code 11724) as transaction platform.

TRADE AND INVEST SECURELY WITH GROWW

Stocks, Mutual fund investments, F&Os, etc., are very popular with individual investors because of their numerous benefits. On Groww, an investor can -

- Invest in Nifty 50 (NSE) & Sensex (BSE) listed stocks

- Diversify across multiple stocks and other instruments

- Start SIP with any amount (as low as Rs. 500)

- Switch regular funds to direct funds

- Start automated monthly investments (SIP), and benefit from many more features

All type of mutual funds are available on Groww.

INVESTING IN MUTUAL FUND PORTFOLIOS

Portfolio is collection of mutual funds designed to meet your investment goals. Investing in mutual fund portfolios helps you in diversifying your investments and reduces the risk. Portfolios also help you in assigning an investment goals and make it easy for you to save for and achieve your goals. You can create a portfolio yourself or ask an expert to build it for you.

ATTENTION INVESTORS

1. For Stock Broking Transaction 'Prevent unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day...Issued in the interest of Investors.

2. For Depository Transaction 'Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL/NSDL on the same day...Issued in the interest of investors.

3. KYC is a one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

4. If you are subscribing to an IPO, there is no need to issue a cheque. Please write the Bank account number and sign the IPO application form to authorize your bank to make payment in case of allotment. In case of non allotment the funds will remain in your bank account.

· Investors should be cautious on unsolicited emails and SMS advising to buy, sell or hold securities and trade only on the basis of informed decision. Investors are advised to invest after conducting appropriate analysis of respective companies and not to blindly follow unfounded rumours, tips etc. Further, you are also requested to share your knowledge or evidence of systemic wrongdoing, potential frauds or unethical behaviour through the anonymous portal facility provided on BSE & NSE website.

· Awareness regarding guidelines on Margin collection

1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

3. Pay 20% upfront margin of the transaction value to trade in cash market segment.

4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.

Issued in the interest of Investors

DISCLAIMER

NextBillion Technology Private Limited (CIN: U65100KA2016PTC092879) is a member of NSE & BSE with SEBI Registration no: INZ000301838, Depository Participant of CDSL Depository with SEBI Registration no: IN-DP-417-2019 and Mutual Fund distributor with AMFI Registration No: ARN-111686. Registered office and Correspondence office - No.11, 2nd floor, 80 FT Road, 4th Block, S.T Bed, Koramangala, Bengaluru – 560034. For any grievances related to Stock Broking/DP, please write to [email protected] , please ensure you carefully read the Risk Disclosure Document as prescribed by SEBI.

Procedure to file a complaint on SEBI SCORES: Register on the SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.

NextBillion Technology Private Limited makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Unless otherwise specified, all returns, expense ratio, NAV, etc are historical and for illustrative purposes only. Future will vary greatly and depends on personal and market circumstances. The information provided by our blog is educational only and is not investment or tax advice.

Mutual fund investments are subject to market risks. Please read all scheme related documents carefully before investing. Past performance of the schemes is neither an indicator nor a guarantee of future performance.

Terms and conditions of the website/app are applicable. Privacy policy of the website is applicable.